跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PANTOPRAZOLE MAGNESIUM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PANTOPRAZOLE MAGNESIUM
Authorized
STANDARD
PANTOPRAZOLE MAGNESIUM
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bdfcd9e3eaffe41e
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
bdfcd9e3eaffe41e
Drug Approval Canada Name
PANTOPRAZOLE MAGNESIUM
Product Name
PANTOPRAZOLE MAGNESIUM
Status
Marketed
Status Date
2023-02-07
Original Market Date
2022-01-21
Din
02519534
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC02 PANTOPRAZOLE
Atc Name
a 02 bc 02
Aig Number
0133229001
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
PANTOPRAZOLE (PANTOPRAZOLE MAGNESIUM HEMIPENTAHYDRATE)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bdfcd9e3eaffe41e
Type
Standard
Back to Health Canada Approvals